Cargando…
DNA and histone deacetylases as targets for neuroblastoma treatment
Neuroblastoma, a tumor of the peripheral sympathetic nervous system, is the most frequent solid extra cranial tumor in children and is a major cause of death from neoplasia in infancy. Still little improvement in therapeutic options has been made, requiring a need for the development of new therapie...
Autores principales: | Stiborová, Marie, Poljaková, Jitka, Eckschlager, Tomáš, Kizek, Rene, Frei, Eva |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Slovak Toxicology Society SETOX
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984128/ https://www.ncbi.nlm.nih.gov/pubmed/21217872 http://dx.doi.org/10.2478/v10102-010-0010-6 |
Ejemplares similares
-
Histone deacetylase inhibitors valproate and trichostatin A are toxic to neuroblastoma cells and modulate cytochrome P450 1A1, 1B1 and 3A4 expression in these cells
por: Hřebačková, Jana, et al.
Publicado: (2009) -
Ellipticine cytotoxicity to cancer cell lines — a comparative study
por: Stiborová, Marie, et al.
Publicado: (2011) -
The comparison of cytotoxicity of the anticancer drugs doxorubicin and ellipticine to human neuroblastoma cells
por: Poljaková, Jitka, et al.
Publicado: (2008) -
The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells
por: Cerna, Tereza, et al.
Publicado: (2018) -
Histone Deacetylase Inhibitors as Anticancer Drugs
por: Eckschlager, Tomas, et al.
Publicado: (2017)